TLDR: INJ has gained more than 30% from its breakout point after clearing a cup-and-handle pattern. The cup-and-handle formation projects a price target near $14 for the Injective token. Inje
Injective has climbed more than 30% from its breakout point after the INJ token cleared a cup-and-handle pattern. Analysts note that the formation points to a target near $14.
At the same time, the network now leads major blockchains in revenue relative to fully diluted market capitalization.
Onchain revenue also feeds a monthly community buyback that removes tokens from supply. These developments place the asset in focus as traders track the next phase of the move.
Ali Charts, a market analyst, shared the technical outlook in a post on X. The analyst stated that the rally has only just begun.
The analyst carried a clear message: INJ may still have room to rise. According to the post, INJ has already moved well beyond the level where the pattern broke.
The post explains that INJ broke out of a cup-and-handle pattern before the recent advance. Since that breakout, the price has gained more than 30%. Notably, the analyst expects the formation to support further upside from the current level.
INJECTIVE: THE RALLY HAS JUST BEGUN
After breaking out of a cup-and-handle pattern, $INJ has already surged more than 30% from the breakout point.
But this technical formation suggests there could still be more upside ahead.
The pattern projects a target near $14, meaning… https://t.co/ci8F8ofCw7pic.twitter.com/o0NEgtvCqx
— Ali Charts (@alicharts) October 16, 2026
The pattern is a common bullish formation in technical analysis. It typically forms a rounded base followed by a brief pullback.
Traders often measure the depth of the cup to estimate a price target. This structure is widely followed by traders who watch for continuation after a breakout.
Based on that measurement, the projection sits near $14. Therefore, the token could extend its gains before the pattern completes.
The analyst described this level as the projected target for the formation. The token would need to continue its advance to reach it.
Injective also shared data on its revenue relative to fully diluted valuation in a separate post on X. The network said it leads all major blockchains on this measure. The post followed the recent price advance in the INJ token.
The comparison shows Injective ahead of Solana and more than 20% ahead of Arbitrum. It also stands over 8x higher than Ethereum.
Injective now leads all major blockchains by revenue to fully diluted market cap.
→ Ahead of Solana → Over 20% ahead of Arbitrum → Over 8x Ethereum → Over 10x Sui and Avalanche
Revenue / FDV is one of the clearest measures of whether a network’s valuation is backed by real… pic.twitter.com/MLLzOCzqJP
— Injective
(@injective) October 15, 2026
Moreover, the ratio exceeds that of Sui and Avalanche by more than 10x. The ratio compares network revenue with the total value of all tokens at full supply.
The network described revenue to FDV as a clear measure of whether a valuation is backed by real usage. In addition, onchain revenue flows into the INJ Community BuyBack. The measure ties valuation to the income that a network actually generates.
This program permanently removes INJ from supply every month. Consequently, the supply of the token declines each month.
Meanwhile, Injective expects revenue to accelerate as it onboards new tokenization initiatives. The network also plans to launch new products in the coming months. Both developments arrived within the same period of price strength.
The post INJ Rallies Over 30% From Breakout as Analyst Projects $14 Target appeared first on Blockonomi.
